Therapeutic area:

MICI

Objective:

Evaluate the impact of the use of a medical remote monitoring application on the management of patients with active IBD.

Health teams, partner scientific experts:

GETAID

Therapeutic area:

Type 2 diabetes

Objective:

Evaluate the clinical and organizational impact of the use of a remote monitoring tool on the management of type 2 diabetic patients who are not treated with insulin and who have comorbidity and are monitored by a general practitioner.

Health teams, partner scientific experts:

Boehringer Ingelheim

Therapeutic area:

Nephrology

Objective:

Evaluate the relevance of an adherence score based solely on purchases of immunosuppressive treatments in pharmacies to predict the appearance of anti-HLA antibodies directed against the graft.

Health teams, partner scientific experts:

CHU Bordeaux and CHU Nantes

Therapeutic area:

Nephrology

Objective:

Evaluate the benefit provided by NephroWise, two years post-transplant, on patient survival as well as on graft survival and rejection.

Health teams, partner scientific experts:

ITUN (Institute of Urologle-Nephrology Transplantation) - INSERM UMR 643

Objective:

Predicting patients' adherence to Continuous Positive Airway Pressure (CPAP) in sleep apnea and identifying the impact of adherence on patients' morbidity and mortality.

Therapeutic area:

Nephrology

Objective:

Predict, throughout the life of a transplant patient, the probability of transplant failure within five years of the prediction time.

Health teams, partner scientific experts:

CHU Nantes - nephrology department, INSERM UMR 1246 SPHERE

Therapeutic area:

Rare liver diseases

Objective:

Estimate the prevalence of each of four rare liver diseases in the general population. (Autoimmune Hepatitis (HAI); Primary Biliary Cholangitis (PBC); Primary Sclerosing Cholangitis (PSC); Intra-hepatic Cholesterol Microlithiasis (LPAC Syndrome).)

Health teams, partner scientific experts:

Albi Patient Association, Coordinating Reference Center for Inflammatory Biliary Tract Diseases and Autoimmune Hepatitis (MIVB-H), Reference Center for Liver Vascular Diseases

Therapeutic area:

Sleep apnea

Objective:

Identify the impact of persistence in Continuous Positive Airway Pressure (CPAP) on patients' morbidity and mortality.

Health teams, partner scientific experts:

Grenoble Alpes University - INSERM - HP2 Laboratory, Resmed Sciences Center

Objective:

Predicting non-persistence and non-adherence to oral cancer treatments for patients with localized breast cancer.

Health teams, partner scientific experts:

Leon Bérard Center, Lyon, France (Heudel); Pasteur Clinic, Toulouse, France (Kanoun); François Baclesse Center, Caen, France (Levy); Saint Louis AP-HP Hospital, Paris, France (Heudel); Saint Louis AP-HP Hospital, Paris, France (Teixeira); Paris, France (Teixeira); Paris City University, France (Teixeira)

Objective:

Predicting non-persistence and non-adherence to oral cancer treatments for patients with metastatic breast cancer.

Health teams, partner scientific experts:

Leon Bérard Center, Lyon, France (Heudel); Pasteur Clinic, Toulouse, France (Kanoun); François Baclesse Center, Caen, France (Levy); Saint Louis AP-HP Hospital, Paris, France (Heudel); Saint Louis AP-HP Hospital, Paris, France (Teixeira); Paris, France (Teixeira); Paris City University, France (Teixeira)

Objective:

Predicting treatment adherence and hospitalizations for patients with bipolar disorders.

Health teams, partner scientific experts:

Foundational Foundation